Zobrazeno 1 - 10
of 154
pro vyhledávání: '"María Hernández Sánchez"'
Autor:
Pedro Aguilar Garrido, Maria Velasco Estevez, Miguel Ángel Navarro Aguadero, María Hernández Sánchez, Prerna Malaney, Marisa Hornbaker, Xiaorui Zhang, Marta Ibañez Navarro, Alejandra Ortiz-Ruiz, Álvaro Otero-Sobrino, Diego Megías, Manuel Pérez, Jesús Gómez, Gadea Mata, Orlando Dominguez, Osvaldo Grana, Eduardo Caleiras, Marta Isasa, Paloma Jimena de Andrés, Sandra Rodriguez, Raúl Torres, Oleksandra Sirozh, Vanesa Lafarga, Joaquín Martínez-Lopez, Sean Post, Miguel Gallardo
Publikováno v:
HemaSphere, Vol 7, p e8819188 (2023)
Externí odkaz:
https://doaj.org/article/31825dcb3d8a4b67a90a4ac36218cf8e
Autor:
María Hernández-Sánchez
Publikováno v:
Encyclopedia, Vol 2, Iss 2, Pp 928-936 (2022)
Genome-editing systems such as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 technology have uncovered new opportunities to model diseases such as chronic lymphocytic leukemia. CRISPR/Cas9 is an important means of advancing
Externí odkaz:
https://doaj.org/article/85290d84b6e0428b8058cd2c02a6234a
Autor:
Jakob Woerner, Yidi Huang, Stephan Hutter, Carmelo Gurnari, Jesús María Hernández Sánchez, Janet Wang, Yimin Huang, Daniel Schnabel, Michael Aaby, Wanying Xu, Vedant Thorat, Dongxu Jiang, Babal K. Jha, Mehmet Koyuturk, Jaroslaw P. Maciejewski, Torsten Haferlach, Thomas LaFramboise
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-13 (2022)
Circulating microbiome has been very little studied for blood malignancies. Here, the authors show specific microbiome signatures in the blood are associated with different types of myeloid malignancies and specific genetic mutations.
Externí odkaz:
https://doaj.org/article/c88a3d229d2e42d081b77068f18c29f0
Autor:
Miguel Quijada-Álamo, María Hernández-Sánchez, Ana-Eugenia Rodríguez-Vicente, Claudia Pérez-Carretero, Alberto Rodríguez-Sánchez, Marta Martín-Izquierdo, Verónica Alonso-Pérez, Ignacio García-Tuñón, José María Bastida, María Jesús Vidal-Manceñido, Josefina Galende, Carlos Aguilar, José Antonio Queizán, Isabel González-Gascón y Marín, José-Ángel Hernández-Rivas, Rocío Benito, José Luis Ordóñez, Jesús-María Hernández-Rivas
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 7, Pp 1-11 (2021)
Abstract BIRC3 is monoallelically deleted in up to 80% of chronic lymphocytic leukemia (CLL) cases harboring del(11q). In addition, truncating mutations in the remaining allele of this gene can lead to BIRC3 biallelic inactivation, which has been sho
Externí odkaz:
https://doaj.org/article/6298fa088832472aaa3af17d993dc8f6
Publikováno v:
Boletin Clinico Hospital Infantil del Estado de Sonora; abr2024, Vol. 41 Issue 1, p12-19, 8p
Autor:
Jorge Alberto Rodríguez-Hernández, Leyden Soto-Cos, Estela Pol-Rodríguez, Carmen María Hernández-Sánchez, Mayra de la C. Pérez-Álvarez, Maydel Pérez-Fuentes
Publikováno v:
Duazary, Vol 17, Iss 4, Pp 89-95 (2020)
Los pacientes que precisan rehabilitaciones extensas, en ocasiones, se les dificulta el tratamiento por el tiempo y visitas repetidas a la institución de salud. Reportamos un caso clínico con estas características, que presentaba, en todos los die
Externí odkaz:
https://doaj.org/article/82283a724858435c8b4eddf069ae8757
Autor:
Elisa ten Hacken, Kendell Clement, Shuqiang Li, María Hernández-Sánchez, Robert Redd, Shu Wang, David Ruff, Michaela Gruber, Kaitlyn Baranowski, Jose Jacob, James Flynn, Keith W. Jones, Donna Neuberg, Kenneth J. Livak, Luca Pinello, Catherine J. Wu
Publikováno v:
Genome Biology, Vol 21, Iss 1, Pp 1-11 (2020)
Abstract CRISPR-Cas9 gene editing has transformed our ability to rapidly interrogate the functional impact of somatic mutations in human cancers. Droplet-based technology enables the analysis of Cas9-introduced gene edits in thousands of single cells
Externí odkaz:
https://doaj.org/article/0fc6668360f84aa68cc28a219254ce26
Autor:
Miguel Quijada‐Álamo, Claudia Pérez‐Carretero, María Hernández‐Sánchez, Ana‐Eugenia Rodríguez‐Vicente, Ana‐Belén Herrero, Jesús‐María Hernández‐Sánchez, Marta Martín‐Izquierdo, Sandra Santos‐Mínguez, Mónica del Rey, Teresa González, Araceli Rubio‐Martínez, Alfonso García de Coca, Julio Dávila‐Valls, José‐Ángel Hernández‐Rivas, Helen Parker, Jonathan C. Strefford, Rocío Benito, José‐Luis Ordóñez, Jesús‐María Hernández‐Rivas
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 2, Pp n/a-n/a (2021)
Abstract Background Several genetic alterations have been identified as driver events in chronic lymphocytic leukemia (CLL) pathogenesis and oncogenic evolution. Concurrent driver alterations usually coexist within the same tumoral clone, but how the
Externí odkaz:
https://doaj.org/article/ee07f326975144ad8bd15cff85606abf
Autor:
Ricard Carrillo Muñoz, José Luis Ballve Moreno, Iván Villar Balboa, Yolanda Rando Matos, Oriol Cunillera Puertolas, Jesús Almeda Ortega, Estrella Rodero Perez, Xavier Monteverde Curto, Carles Rubio Ripollès, Noemí Moreno Farres, Austria Matos Mendez, Jean Carlos Gomez Nova, Marta Bardina Santos, Johan Josué Villarreal Miñano, Diana Lizzeth Pacheco Erazo, Anabella María Hernández Sánchez, Grupo de estudio del vértigo en atención primaria Florida
Publikováno v:
BMC Family Practice, Vol 20, Iss 1, Pp 1-11 (2019)
Abstract Background Benign paroxysmal positional vertigo (BPPV) is the most common cause of vertigo. Little is known on how posterior canal BPPV affects health-related quality of life in patients diagnosed and treated at primary care facilities or on
Externí odkaz:
https://doaj.org/article/7b8631b79fee45bfac1dc52314a6738e
Autor:
Raquel Ancos-Pintado, Irene Bragado-García, María Luz Morales, Roberto García-Vicente, Andrés Arroyo-Barea, Alba Rodríguez-García, Joaquín Martínez-López, María Linares, María Hernández-Sánchez
Publikováno v:
Cancers, Vol 14, Iss 15, p 3612 (2022)
CRISPR is becoming an indispensable tool in biological research, revolutionizing diverse fields of medical research and biotechnology. In the last few years, several CRISPR-based genome-targeting tools have been translated for the study of hematologi
Externí odkaz:
https://doaj.org/article/d9591c79be144e50881f7b404091e66f